UiPath, Inc. (PATH)
NYSE · Price as of · Nasdaq Real Time Price
- Analysts16
- Implied upside-18.0%
- Target range$10.98 to $17.00
- EPS expected$0.15 -1.7%
- A year ago$0.15
- Revenue expected$397.8M +10.0%
- Estimate range$0.11 to $0.17
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | August 19, 2026 | PRIMARY DOCUMENT |
| 144 | August 19, 2026 | View on EDGAR |
| 144 | August 14, 2026 | View on EDGAR |
| 4 | August 14, 2026 | PRIMARY DOCUMENT |
| 144 | August 13, 2026 | View on EDGAR |
| SCHEDULE 13G/A | July 15, 2026 | View on EDGAR |
| 4 | July 2, 2026 | PRIMARY DOCUMENT |
| 4 | July 2, 2026 | PRIMARY DOCUMENT |
Articles that mention UiPath without it being the main subject.
Frequently asked questions
When does PATH report earnings?
UiPath, Inc. (PATH) is scheduled to report quarterly results on September 3, 2026, after the close. The 19-analyst consensus is $0.15 per share on revenue of $397.8M for the quarter ended July 31, 2026, against $0.15 and $361.7M a year earlier. It has beaten the consensus EPS estimate in 3 of the last four quarters.
What do analysts expect for PATH?
16 analysts cover UiPath, Inc. (PATH). The consensus rating is Hold. The average price target is $13.44, in a range of $10.98 to $17.00.
Are insiders buying or selling PATH?
We have no qualifying Form 4 insider purchases or sales on record for UiPath, Inc. (PATH). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see PATH SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed August 19, 2026.
